Posted on Leave a comment

Disruptive Approaches in Major Depressive Disorder Pipeline: Assessing the Transformative Potential of 75+ Key Companies | AbbVie, Gedeon Richter, Intra-Cellular Therapies, GH Research, and others

(Albany, United States) As per DelveInsight’s assessment, globally, the Major Depressive Disorder pipeline constitutes 75+ key companies continuously working towards developing 75+ Major Depressive Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.   In the Major Depressive Disorder Pipeline Report, a detailed description of the […]

Posted on Leave a comment

Exploring the Frontier of Pulmonary Arterial Hypertension Treatment: In-Depth Analysis of 55+ Key Companies in the Pipeline | Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies

(Albany, United States) As per DelveInsight’s assessment, globally, the Pulmonary Arterial Hypertension pipeline constitutes 55+ key companies continuously working towards developing 55+ Pulmonary Arterial Hypertension treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.   In the Pulmonary Arterial Hypertension Pipeline Report, detailed description of the drug […]

Posted on Leave a comment

Glioblastoma Multiforme (GBM) Market to Grow at a Substantial Growth Rate During the Forecast Period (2023-2032) – DelveInsight | Bayer, MedImmune, DNAtrix, Chimerix, Medicenna, Genentech, Merck

Delveinsight Business Research LLP The Glioblastoma Multiforme Market size in the seven major markets was estimated to be USD 1,022.1 Million in 2020, which is expected to grow by 2032. As per DelveInsight, the Glioblastoma Multiforme Market is anticipated to evolve immensely in the coming years owing to the rise in the number of prevalent […]

Posted on Leave a comment

Peritoneal Cancer Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Seagen, Mersana, ImmunoGen, Elucida, Rhizen, Green3Bio, Oncoinvent, OncoMed

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 60+ key pharma and biotech companies are working on 60+ pipeline drugs in the Peritoneal Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and […]

Posted on Leave a comment

Pioneering Treatment Strategies in Atopic Dermatitis Pipeline: Examining the Groundbreaking Work of 100+ Key Companies | Dermavant Sciences, Pfizer, AOBiome, Allakos Inc., E-nitiate Biopharmaceuticals

(Albany, United States) As per DelveInsight’s assessment, globally, the Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 110+ Atopic Dermatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.   In the Atopic Dermatitis Pipeline Report, detailed description of the drug is given which […]

Posted on Leave a comment

Syncope Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies|Companies-Teva Pharmaceuticals, Mylen Pharmaceuticals

DelveInsight Business Research LLP DelveInsight’s “Syncope Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Syncope, historical and forecasted epidemiology as well as the Syncope market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. DelveInsight’s “Syncope Market Insights, Epidemiology, and Market Forecast-2032” report […]

Posted on Leave a comment

Plaque Psoriasis Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Updated) | Arcutis Biotherapeutics, Affibody, Akeso Biopharma, Dong-A ST Co., Ltd., DelArrivo, Inc., and others

(Albany, United States) As per DelveInsight’s assessment, globally, the Plaque Psoriasis pipeline constitutes 75+ key companies continuously working towards developing 75+ Plaque Psoriasis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.   In the Plaque Psoriasis pipeline report, detailed description of the drug is given which […]

Posted on Leave a comment

Hot Flashes Market expected to rise | Key Companies – Veru Healthcare, Fervent Pharmaceuticals, Ogeda, Bayer, Lundbeck A/S, TherapeuticsMD, MenoGeniX, Mitsubishi Tanabe Pharma, QUE Oncology

Hot Flashes Market DelveInsight’s “Hot Flashes Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Hot Flashes, historical and forecasted epidemiology as well as the Hot Flashes market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The Hot Flashes market growth is driven […]

Posted on Leave a comment

Fibromyalgia Market to Register Stunning Growth During the Forecast Period (2023-2032) – DelveInsight | Key Companies – AppliedVR, Aptinyx, Tryp Therapeutics, Scilex, Virios, TRYP Therapeutics, UCB

Delveinsight Business Research LLP As per DelveInsight, the Fibromyalgia Market is anticipated to evolve immensely in the coming years owing to the increase in the number of patients in the 7MM and the launch of novel therapies in the market. DelveInsight’s “Fibromyalgia Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of […]

Posted on Leave a comment

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Trends, Size, Share, Growth, Industry Analysis, Advance Technology and Forecast 2028

Roche received FDA clearance for the COVID-19 PCR test for use on cobas 6800/8800 systems. The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated, high-throughput platform to receive FDA 510(k) clearance. Digital PCR (dPCR) and Real-time PCR (qPCR) Market in terms of revenue was estimated to be […]